Jifeng Yu
25PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (25)
Sort by Publication Date:
|May 09, 2024
A novel anti-LAG-3/TIGIT bispecific antibody exhibits potent anti-tumor efficacy in mouse models as monotherapy or in combination with PD-1 antibody.Tongcheng Dai, Hao Sun, Tyler Liban
|May 08, 2024
Bispecific antibodies targeting CD20xCD3 in immunotherapy for adult B-cell lymphoma: insights from the 65th American Society of Hematology 2023 annual meeting.Hao Sun, Haizhou Xing, Lijie Han
|Mar 20, 2024
Bispecific antibodies in immunotherapy for adult acute leukemia: latest updates from the 65th American Society of Hematology 2023 Annual Meeting.Lijie Han, Haizhou Xing, Weijie Cao
|Jan 27, 2024
Targeting CD24/Siglec-10 signal pathway for cancer immunotherapy: recent advances and future directions.Xingchen Li, Wenzhi Tian, Zhongxing Jiang
|Jan 16, 2024
Targeting TIGIT for cancer immunotherapy: recent advances and future directions.Peng Zhang, Xinyuan Liu, Zhuoyu Gu
|Oct 18, 2023
Bispecific antibodies as monotherapy or in combinations for hematological malignancies: latest updates from the EHA 2023 annual meeting.Xingchen Li, Peng Zhang, Hao Sun
Pageof 5
